Keyphrases
Thyroid Hormones
100%
Integrin
73%
Venous Thromboembolism
71%
Anticoagulation
59%
Myeloproliferative Neoplasms
58%
Thrombosis
49%
Israel
48%
Myelofibrosis
46%
Confidence Interval
46%
Anemia
45%
Direct Oral Anticoagulants
42%
Ovarian Cancer
40%
Antiphospholipid Syndrome
39%
Low Molecular Weight Heparin
38%
Polycythemia Vera
36%
Israeli
35%
Chronic Myeloid Leukemia
33%
Anticoagulants
32%
Hazard Ratio
32%
Essential Thrombocythemia
31%
Platelets
29%
Bleeding
28%
OVCAR-3
26%
Tranexamic Acid
26%
Total Knee Replacement
26%
Major Bleeding
26%
Clinical Outcomes
25%
Ruxolitinib
25%
Recurrent Venous Thromboembolism
25%
Thrombophilia
24%
Vena Cava Filters
23%
High-grade Serous Ovarian Cancer (HGSOC)
23%
Venous Thrombosis
23%
Atrial Fibrillation
22%
Deep Vein Thrombosis
22%
Tyrosine Kinase Inhibitor
22%
Transfusion
22%
Blood Storage
22%
Myeloma Cells
22%
Clinical Significance
21%
Warfarin
21%
Red Cells
21%
Enoxaparin
20%
Vitamin K Antagonists
20%
Pulmonary Embolism
20%
Splanchnic Vein Thrombosis
20%
Hematological Malignancies
20%
Physician Survey
19%
Hemophagocytic Lymphohistiocytosis
19%
Bone Marrow
19%
Medicine and Dentistry
Venous Thromboembolism
71%
Anticoagulation
67%
Thyroid Hormone
65%
Myeloproliferative Neoplasm
56%
Thrombosis
56%
Integrin
54%
Ovarian Cancer
47%
Diseases
46%
Malignant Neoplasm
40%
Phlebothrombosis
40%
Anemia
38%
Antithrombotic
36%
Erythrocyte
34%
Bleeding
34%
Antiphospholipid Syndrome
33%
Myelofibrosis
30%
Platelet
27%
Low Molecular Weight Heparin
26%
Venae cavae
26%
Major Bleeding
26%
Hazard Ratio
25%
Inferior Vena Cava Filter
25%
Prevalence
25%
Internal Medicine
23%
Retrospective Study
23%
Deep Vein Thrombosis
22%
Polycythemia vera
21%
Recurrent Disease
21%
Pulmonary Embolism
21%
Direct Oral Anticoagulant
21%
COVID-19
21%
Thromboembolism
21%
Hematologic Malignancy
20%
Tranexamic Acid
19%
Total Knee Arthroplasty
19%
Hemophagocytic Syndrome
19%
Vitamin K Antagonist
19%
Cancer
18%
Infection
17%
B-Cell Chronic Lymphocytic Leukemia
17%
Thrombophilia
17%
Thrombocytosis
16%
Cell Line
16%
Antiphospholipid Antibody
16%
Randomized Controlled Trial
15%
Blood Storage
15%
Mitogen-Activated Protein Kinase
15%
Odds Ratio
15%
Neoplasm
14%
Thyroid Hormone Derivative
14%
Pharmacology, Toxicology and Pharmaceutical Science
Thyroid Hormone
80%
Venous Thromboembolism
67%
Bleeding
57%
Malignant Neoplasm
47%
Integrin
47%
Anticoagulant Agent
41%
Myelofibrosis
40%
Ovary Cancer
39%
Diseases
37%
Direct Oral Anticoagulant
35%
Myeloma
28%
Low Molecular Weight Heparin
28%
Thromboembolism
27%
Tranexamic Acid
26%
Chronic Myeloid Leukemia
26%
Ruxolitinib
26%
Thrombosis
24%
Myeloproliferative Neoplasm
23%
Polycythemia vera
23%
Neoplasm
23%
Atrial Fibrillation
21%
Multiple Myeloma
21%
Warfarin
21%
Chronic Lymphatic Leukemia
19%
Anemia
19%
Hematologic Malignancy
18%
Retrospective Study
17%
Thrombin
17%
Clinical Study
17%
Infection
16%
Deep Vein Thrombosis
15%
Protein Tyrosine Kinase Inhibitor
15%
Vein Thrombosis
15%
Antivitamin K
15%
Randomized Controlled Trial
15%
Cohort Study
14%
Thyroid Hormone Derivative
14%
Tumor Growth
14%
Blood Clotting Factor 10a
13%
Enoxaparin
13%
Cardiolipin Antibody
13%
Hemophagocytic Syndrome
13%
Thrombotic Thrombocytopenic Purpura
13%
Nonhodgkin Lymphoma
13%
Phosphatidylserine
13%
Desmopressin
13%
Dexamethasone
13%
Momelotinib
13%
Danazol
13%
Fedratinib
13%